Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.20

+0.1%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (19986)	5/4/1998 10:19:00 AM
From: bob zagorin	of 32384

Henry (or anyone), would you compare the cellular mechanism involved in anti-angiogenesis with that of anti-code as in Genta's program. Here is a paragraph recent Genta release as reference. Thanks. "...As an antisense compound, G3139 is designed to act toward a specific gene and prevent it from triggering the production of disease-related protein. G3139's target, the bcl-2 gene, interferes in the normal mortality of cells (apoptosis) and has been implicated in prostate cancer, non-Hodgkin's lymphoma, melanoma, breast and other cancers...."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next